Our PATHWAYS TO THE FUTURE story is about an unconventional approach to developing new psychiatric drugs. Based on an initiative by the National Institute of Mental Health, it’s called “Fast-Fail” and is designed to weed out the weakest drug candidates early in the process, to save time and money. In its first comprehensive test, a team led by two BBRF grantees and including 11 other BBRF grantees, Scientific Council members and prize winners, demonstrated the approach using a potential drug to treat anhedonia—the inability to experience or seek pleasure—which is seen in a number of psychiatric disorders including depression, anxiety, and PTSD.
Read More
View all of the presentations from our 2020 International Mental Health Research Virtual Symposium including Dr. Myrna M. Weissman, Ph.D.'s Keynote Presentation and research updates from our Outstanding Achievement Prizewinners.
Read More
Q&A with Dilip Jeste, M.D., on the role of wisdom in dealing with what he has called “an epidemic of loneliness and despair” in America.
Read More
Efforts by 2020 Pardes Prize honorees – Dr. Myrna Weissman, Sir Michael Rutter, and Dr. E. Fuller Torrey -- have had a profound impact on improving the lives of people with mental illness.
Read More
Eight winners of 2020 BBRF Outstanding Achievement Prizes discuss their research. Highlights of BBRF’s 2020 International Mental Health Virtual Symposium.
Read More